Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Benign Hematology
•
Hospital Medicine
Would you start a patient with sickle cell disease and COVID-19 on prophylactic anticoagulation?
Related Questions
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
What is your approach to optimizing pre-operative hemoglobin in patients with sickle cell disease?
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
What experience have you had with familial clustering of polycythemia vera?
Can defibrotide be given safely for VOD in patients with refractory thrombocytopenia to platelet transfusions?
What hydroxyurea dose do you target for HbSC disease?
